Runway Growth Finance reports 10% NAV decline as two major loans go non-accrual

Filed May 7, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 12, 2025 · ~2 min read

Key Changes

• high

  Two portfolio companies—Marley Spoon ($68M cost basis) and Blueshift Labs ($32M cost basis)—placed on non-accrual in Q1 2026, driving total non-accruals from 0.5% to 6.1% of portfolio and marking down $51M in fair value.

  MD&A: Non-Accrual Investments verify on EDGAR →
• high

  Net asset value per share fell from $13.48 to $12.13 (down 10%) year-over-year, driven by $46.7M in unrealized losses and net investment income declining 32% to $0.29 per share.

  MD&A: Financial Results verify on EDGAR →
• high

  Portfolio yield compressed 120 basis points to 14.2% from 15.4% prior year, while total investment income dropped 17% to $29.5M as credit deterioration and lower rates weighed on earnings.

  MD&A: Portfolio Yield verify on EDGAR →